DNA (Cytosine-5-)-Methyltransferases
"DNA (Cytosine-5-)-Methyltransferases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes that catalyzes the transfer of a methyl group from S-ADENOSYLMETHIONINE to the 5-position of CYTOSINE residues in DNA.
| Descriptor ID |
D004248
|
| MeSH Number(s) |
D08.811.913.555.500.350.100.500
|
| Concept/Terms |
DNA (Cytosine-5-)-Methyltransferases- DNA (Cytosine-5-)-Methyltransferases
- DNA (Cytosine-5-)-Methyltransferase
- DNA Cytosine-5-Methylase
- Cytosine-5-Methylase, DNA
- DNA Cytosine 5 Methylase
- DNA (Cytosine 5) Methyltransferase
|
Below are MeSH descriptors whose meaning is more general than "DNA (Cytosine-5-)-Methyltransferases".
Below are MeSH descriptors whose meaning is more specific than "DNA (Cytosine-5-)-Methyltransferases".
This graph shows the total number of publications written about "DNA (Cytosine-5-)-Methyltransferases" by people in this website by year, and whether "DNA (Cytosine-5-)-Methyltransferases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 3 | 2 | 5 |
| 2018 | 4 | 3 | 7 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "DNA (Cytosine-5-)-Methyltransferases" by people in Profiles.
-
Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure. JAMA Cardiol. 2020 10 01; 5(10):1170-1175.
-
Mutations in the DNA methylation pathway predict clinical efficacy to hypomethylating agents in myelodysplastic syndromes: a meta-analysis. Leuk Res. 2019 05; 80:11-18.
-
MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML. Blood. 2018 10 04; 132(14):1526-1534.
-
Resveratrol Modulates SIRT1 and DNMT Functions and Restores LINE-1 Methylation Levels in ARPE-19 Cells under Oxidative Stress and Inflammation. Int J Mol Sci. 2018 Jul 20; 19(7).
-
Haemophagocytic lymphohistiocytosis occurred during induction chemotherapy in an acute monocytic leukemia patient with FLT3-ITD and DNMT3A mutations. BMC Cancer. 2018 May 29; 18(1):604.
-
Gain-of-function mutations in DNMT3A in patients with paraganglioma. Genet Med. 2018 12; 20(12):1644-1651.
-
Deciphering the role of dimer interface in intrinsic dynamics and allosteric pathways underlying the functional transformation of DNMT3A. Biochim Biophys Acta Gen Subj. 2018 Jul; 1862(7):1667-1679.
-
Implications of Mutation Profiling in Myeloid Malignancies-PART 1: Myelodysplastic Syndromes and Acute Myeloid Leukemia. Oncology (Williston Park). 2018 04 15; 32(4):e38-e44.
-
Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells. Cell Physiol Biochem. 2018; 45(6):2548-2559.
-
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia. Nat Commun. 2017 12 19; 8(1):2126.